CLINICAL_TRIALS
trial_result
· 2013-04-11
Clinical Trial Update: Augmentation Study of Levetiracetam in Obsessive Compulsive Disorder [Phase 2, Phase 3]
Summary
A Phase 2/3 augmentation trial of levetiracetam for obsessive-compulsive disorder was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Duke University | Conditions: Obsessive-Compulsive Disorder | Phase 2, Phase 3 | Status: TERMINATED